Summary
Naloxone 0.8 mg im administered to eight healthy subjects did not affect the serum levels of GH, LH, FSH, PRL, TSH and cortisol. Pretreatment with naloxone 0.8 mg increased TRH-induced TSH and PRL release in six healthy subjects. The same pretreatment caused an enhancement of haloperidol-induced PRL secretion in further other group of six subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blankstein J, Beyes F, Winter J, Faiman C (1979) Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and hyperprolactinemic patients. Clin Endocrinol 11: 475–479
Bruni JF, Van Vugt D, Marshall S, Meites J (1977) Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci 21: 461–466
Chihara K, Arimura A, Coy DH, Schally AV (1978) Studies on the interaction of endorphins, substance P, and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology 102: 281–290
Dupont A, Cusan L, Labrie F, Coy DH, Li CH (1977) Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine enkephalin. Biochem Biophys Res Commun 75: 76–81
Grossman A, Moult PJA, Gaillard RC, Delitala G, Toff WD, Lesley HR, Besser GM (1981) The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone. Clin Endocrinol 14: 41–47
Jaffe JH, Martin WR (1975) Narcotic analgesic and antagonists. In: Goodman S, Gilman A (eds) The pharmacological basis of therapeutics, MacMillan, New York, pp 255–283
Janowski D, Judd L, Heey L, Roitman N, Parker D, Segall D (1978) Negative naloxone effects on serum prolactin. Lancet 2: 637
Lee S, Panerai AE, Bellabarba D, Friesen HG (1980) Effect of endocrine modifications and pharmacological treatments on brain and pituitary concentrations of β-endorphin. Endocrinology 107: 245–249
Meites J, Bruni JF, Van Vugt DA, Smith AF (1979) Relation of endogenous opioid peptides and morphine to neuroendocrine functions. Life Sci 24: 1325–1336
Midgley AR Jr (1966) Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology 79: 10–18
Midgley AR Jr (1967) Radioimmunoassay for human follicle stimulating hormone. J Clin Endocrinol Metab 27: 295–298
Molinatti GM, Massara E, Strumia F, Pennisi P, Scassellati GA, Vaccheri L (1969) Radioimmunoassay of human growth hormone. J Nucl Biol Med 12: 26–31
Morley JE, Baranetsky NG, Wingert TD, Carlson HE, Hershman JM, Melmed S, Levin SR, Jamison KR, Weitzman R, Chang RJ, Varner AA (1980) Endocrine effects of naloxone-induced opiate receptor blockade. J Clin Endocrinol Metab 50: 251–257
Odell WD, Wilber JF, Paul WE (1965) Radioimmunoassay of thyrotropin in human serum. J Clin Endocrinol Metab 25: 1179–1188
Quigley ME, Sheehan KL, Casper RLF, Yen SSG (1980) Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma. J Clin Endocrinol Metab 50: 427–430
Rivier C, Vale W, Ling N, Brown M, Guillemin R (1977) Stimulation in vivo of the secretion of prolactin and growth hormone by β-endorphin. Endocrinology 100: 238–241
Rubin P, Swezey S, Blasche T (1979) Naloxone lowers plasms prolactin in man. Lancet 1: 1293
Ruder HI, Guy PL, Lipsett MB (1972) Radioimmunoassay for cortisol in plasma and urine. J Clin Endocrinol Metab 35: 219–224
Sinha YN, Selby FW, Lewis UJ, Vanderlaan WP (1973) A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab 36: 509–516
Spiler IJ, Motolich ME (1980) Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors. J Clin Endocrinol Metab 50: 516–520
Stubbs WA, Delitala G, Jones A, Jeffcoate WJ, Edwards CRW, Ratter SJ, Besser GM, Bloom SR, Alberti KGMM (1978) Hormonal and metabolic responses to an enkephalin analogue in normal men. Lancet 2: 1225–1227
Volavka J, Cho D, Mallya A (1979) Naloxone increases ACTH and cortisol levels in man. N Engl J Med 300: 1056–1057
Von Graffenried B, Del Pozo E, Krebs E, Pöldinger W, Burmeister P, Kerp L (1978) Effect of the synthetic enkephalin analogue KF 33–824 in man. Nture 272: 729–730
Wakabayashi I, Demura R, Miki N, Ohmura E, Miyoshi H, Shizume K (1980) Failure of naloxone to influence plasma growth hormone, prolactin and cortisol secretions induced by insulin hypoglycemia. J Clin Endocrinol Metab 50: 597–599
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rolandi, E., Marabini, A., Magnani, G. et al. Influence of low doses of naloxone on pituitary secretion in man. Eur J Clin Pharmacol 22, 213–216 (1982). https://doi.org/10.1007/BF00545217
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00545217